Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.9262364741648358e-08,4.279166666666667,76.01987791643225,"['RPL34', 'RPLP1', 'RPL36A', 'RPL10A', 'RPL9', 'RPL7', 'RPS15A', 'RPS18', 'RPL38', 'RPS2', 'RPS11', 'RPS27A', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPL19', 'RPL41', 'RPL35A', 'RPS3A', 'RPL23A', 'RPS26', 'RPS25', 'RPS29', 'RPL37A', 'RPL26', 'FAU', 'RPS21']",8.956999604866487e-06,0,0,28
2,Complement system WP2806,4.783308990702102e-06,6.451620648259304,79.03479161179132,"['SELPLG', 'CD93', 'PROS1', 'C5AR1', 'FPR1', 'F13A1', 'FCGR3A', 'ITGAX', 'SPP1', 'VSIG4', 'CALR', 'CD55', 'TLR2']",0.0011121193403382387,0,0,13
3,NRF2 pathway WP2884,1.5425321799119634e-05,4.6922843716840985,51.988165288291306,"['HSP90AA1', 'PDGFB', 'SLC2A3', 'NRG1', 'SLC2A5', 'SLC6A1', 'SLC5A3', 'SLC6A6', 'DNAJB1', 'FTH1', 'HMOX1', 'FGF13', 'FTL', 'PPARD', 'HSPA1A']",0.002390924878863543,0,0,15
4,Nuclear Receptors Meta-Pathway WP2882,2.6264178905066456e-05,2.76799291479371,29.194864308831775,"['PDGFB', 'TNFAIP3', 'SLC2A3', 'SLC6A1', 'SLC2A5', 'SLC5A3', 'DNAJB1', 'SEC14L1', 'FTH1', 'ENC1', 'PDE4B', 'HMOX1', 'PLTP', 'HSP90AA1', 'STAT3', 'NRG1', 'SLC6A6', 'SLC7A5', 'SCD', 'BHLHE40', 'BAX', 'FGF13', 'CPEB4', 'PPARD', 'HSPA1A', 'FKBP5', 'FTL']",0.0030532107977139754,0,0,27
5,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.901657546047258e-05,3.067874590902623,29.87401851584783,"['UQCRB', 'NDUFB10', 'NDUFA4', 'COX4I1', 'NDUFA3', 'NDUFB3', 'NDUFA1', 'ATP5MC3', 'UQCR11', 'UQCR10', 'COX5B', 'COX6C', 'COX7A1', 'COX7C', 'ATP5F1E', 'ATP5MC1', 'UQCRQ', 'NDUFS6', 'UQCRFS1', 'SLC25A5', 'ATP5MF']",0.00548854151782395,0,0,21
6,Complement and Coagulation Cascades WP558,0.00047446271033848816,7.332995951417004,56.12181979438537,"['C1QB', 'C1QA', 'PROS1', 'C5AR1', 'PLAT', 'CD55', 'C1QC']",0.03504496719811965,0,0,7
7,Complement Activation WP545,0.0006035356891164205,33.424731182795696,247.7676847399627,"['C1QB', 'C1QA', 'CD55', 'C1QC']",0.03504496719811965,0,0,4
8,"GPCRs, Class A Rhodopsin-like WP455",0.0006595448894503523,5.590990990990991,40.94819729821474,"['P2RY12', 'CX3CR1', 'P2RY13', 'CHRM3', 'CYSLTR1', 'HRH2', 'GPR65', 'FPR1']",0.03504496719811965,0,0,8
9,Endochondral Ossification with Skeletal Dysplasias WP4808,0.0007536552085617128,4.720737483085251,33.944819654212814,"['HDAC4', 'SCIN', 'HMGCS1', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'SLC38A2', 'CALM2']",0.03504496719811965,0,0,9
10,Endochondral Ossification WP474,0.0007536552085617128,4.720737483085251,33.944819654212814,"['HDAC4', 'SCIN', 'HMGCS1', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'SLC38A2', 'CALM2']",0.03504496719811965,0,0,9
11,Genes targeted by miRNAs in adipocytes WP1992,0.0016564085284792257,16.70967741935484,106.99379492858094,"['HDAC4', 'GJA1', 'TMSB4X', 'IGF1']",0.07002090597662182,0,0,4
12,Nonalcoholic fatty liver disease WP4396,0.0021692436128527984,2.160676532769556,13.252243183779777,"['XBP1', 'UQCRB', 'NDUFB10', 'NDUFA4', 'INSR', 'COX4I1', 'NDUFA3', 'NDUFB3', 'NDUFA1', 'UQCR11', 'UQCR10', 'COX5B', 'COX6C', 'COX7A1', 'COX7C', 'VMP1', 'UQCRQ', 'NDUFS6', 'MLX', 'CYCS', 'UQCRFS1', 'BAX']",0.08405818999804594,0,0,22
13,Spinal Cord Injury WP2431,0.0026608800455763383,2.965473145780051,17.582581985148398,"['C1QB', 'GJA1', 'ZFP36', 'GAP43', 'FCGR2A', 'APEX1', 'TNFSF13', 'MIF', 'TLR4', 'AIF1', 'TNFSF13B', 'RHOB']",0.09517763239946132,0,0,12
14,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.0041228936768681855,3.4299421823102474,18.83449855745553,"['RYR2', 'GJA1', 'CACNB4', 'CACNA2D3', 'ITGAV', 'CACNA1D', 'CTNNA3', 'CACNA1C', 'ACTG1']",0.13693896855312188,0,0,9
15,Photodynamic therapy-induced unfolded protein response WP3613,0.0046681271932293225,5.019946091644205,26.942037205450344,"['DNAJC3', 'XBP1', 'HSPA5', 'DNAJB11', 'CALR', 'HSP90B1']",0.1400563912640264,0,0,6
16,Oxidative Damage WP3941,0.004819144645643919,4.186234817813765,22.334227636291573,"['C1QB', 'C1QA', 'CDKN1A', 'C5AR1', 'CYCS', 'TNFRSF1B', 'C1QC']",0.1400563912640264,0,0,7
17,Mitochondrial CIV Assembly WP4922,0.006425313783566664,3.906522717049033,19.71821174309082,"['PET100', 'NDUFA4', 'COX4I1', 'COX14', 'COX5B', 'COX6C', 'COX7C']",0.17575122996226464,0,0,7
18,Mitochondrial complex III assembly WP4921,0.00868187378057997,5.223755047106326,24.794646837707933,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10']",0.21965628590429856,0,0,5
19,Lung fibrosis WP3624,0.008975203079960586,4.181940700808625,19.710698104609314,"['CEBPB', 'PDGFB', 'SPP1', 'HMOX1', 'ATP11A', 'IGF1']",0.21965628590429856,0,0,6
20,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.00970575987867582,1.8292257644762524,8.478526845688595,"['IFNAR2', 'CDKN1A', 'HSP90AA1', 'IL4R', 'PFKFB3', 'ANGPT2', 'INSR', 'PDGFB', 'SLC2A3', 'IGF1', 'HIF1A', 'HSP90B1', 'GNG10', 'GNG3', 'FGF14', 'DDIT4', 'SPP1', 'ITGAX', 'GRB2', 'ITGAV', 'FGF13', 'JAK3', 'CREB5']",0.2231285757421455,0,0,23
21,PI3K-Akt signaling pathway WP4172,0.010637056277733384,1.8118337093135675,8.231906109124331,"['IFNAR2', 'CDKN1A', 'HSP90AA1', 'IL4R', 'ANGPT2', 'INSR', 'PDGFB', 'IGF1', 'HSP90B1', 'GNG10', 'CCND3', 'GNG3', 'FGF14', 'DDIT4', 'SPP1', 'GRB2', 'ITGAV', 'FGF13', 'PIK3AP1', 'JAK3', 'TLR4', 'TLR2', 'CREB5']",0.2231285757421455,0,0,23
22,Vitamin D Receptor Pathway WP2877,0.011153163032199168,2.493344090359016,11.210155169543917,"['CDKN1A', 'DUSP10', 'BCL6', 'SATB1', 'CREG2', 'S100A6', 'SPP1', 'TNFAIP3', 'CD14', 'HIF1A', 'PPARD']",0.2231285757421455,0,0,11
23,Monoamine GPCRs WP58,0.011516313586691381,inf,inf,"['CHRM3', 'HRH2']",0.2231285757421455,0,0,2
24,Osteoblast Signaling WP322,0.011516313586691381,inf,inf,"['PDGFB', 'ITGAV']",0.2231285757421455,0,0,2
25,Differentiation Pathway WP2848,0.016302659592452064,5.566308243727598,22.913301652223165,"['NOTCH1', 'WNT5A', 'PDGFB', 'IGF1']",0.2807680263144522,0,0,4
26,"GPCRs, Other WP117",0.016302659592452064,5.566308243727598,22.913301652223165,"['CHRM3', 'ADGRE2', 'P2RY13', 'ADGRL2']",0.2807680263144522,0,0,4
27,Iron metabolism in placenta WP2007,0.016302659592452064,5.566308243727598,22.913301652223165,"['STEAP3', 'FTH1', 'SLC40A1', 'HAMP']",0.2807680263144522,0,0,4
28,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.019226128101723187,8.342281879194632,32.96440243233851,"['CDKN1A', 'SPP1', 'ENPP1']",0.2883919215258478,0,0,3
29,Macrophage markers WP4146,0.019226128101723187,8.342281879194632,32.96440243233851,"['CD163', 'CD83', 'CD14']",0.2883919215258478,0,0,3
30,Platelet-mediated interactions with vascular and circulating cells WP4462,0.019226128101723187,8.342281879194632,32.96440243233851,"['SELPLG', 'TLR4', 'TLR2']",0.2883919215258478,0,0,3
31,Pyrimidine metabolism and related diseases WP4225,0.019226128101723187,8.342281879194632,32.96440243233851,"['NT5C', 'DPYD', 'TYMP']",0.2883919215258478,0,0,3
32,Adipogenesis WP236,0.02299290083648205,2.1947405828002844,8.279811975623838,"['CDKN1A', 'CEBPB', 'CEBPD', 'SCD', 'NAMPT', 'STAT3', 'RORA', 'MIF', 'IGF1', 'HIF1A', 'PPARD']",0.3308621584438938,0,0,11
33,Genes controlling nephrogenesis WP4823,0.02348054027666343,4.770353302611367,17.896377662137823,"['ROBO2', 'CXCL12', 'PDGFB', 'NCK2']",0.3308621584438938,0,0,4
34,Ferroptosis WP4313,0.02528575682410672,2.7876743139901037,10.251711353812896,"['STEAP3', 'MAP1LC3A', 'ACSL1', 'FTH1', 'SLC40A1', 'HMOX1', 'FTL']",0.3458199095061654,0,0,7
35,Glucocorticoid Receptor Pathway WP2880,0.03034529676220234,2.660532450006134,9.298863522089395,"['HSP90AA1', 'SEC14L1', 'ENC1', 'BHLHE40', 'PDE4B', 'TNFAIP3', 'CPEB4']",0.3543654196518801,0,0,7
36,Biomarkers for pyrimidine metabolism disorders WP4584,0.03099295189575303,6.255704697986578,21.732289710824634,"['NT5C', 'DPYD', 'TYMP']",0.3543654196518801,0,0,3
37,Development and heterogeneity of the ILC family WP3893,0.03099295189575303,6.255704697986578,21.732289710824634,"['IL15', 'ZBTB16', 'RORA']",0.3543654196518801,0,0,3
38,Differentiation of white and brown adipocyte WP2895,0.03099295189575303,6.255704697986578,21.732289710824634,"['PLAC8', 'CEBPB', 'PPARGC1B']",0.3543654196518801,0,0,3
39,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.03099295189575303,6.255704697986578,21.732289710824634,"['IL10RB', 'STAT3', 'HMOX1']",0.3543654196518801,0,0,3
40,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.03208173221275929,16.66756032171582,57.32754871146721,"['CDKN1A', 'HIF1A']",0.3543654196518801,0,0,2
41,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.03208173221275929,16.66756032171582,57.32754871146721,"['STAT3', 'BAX']",0.3543654196518801,0,0,2
42,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.03229435071001267,4.173387096774194,14.326666001744552,"['STAT3', 'SPP1', 'IGF1', 'TLR4']",0.3543654196518801,0,0,4
43,TYROBP causal network in microglia WP3945,0.032769275365657734,2.1468278785351957,7.338424299508169,"['IGSF6', 'ADAP2', 'DPYD', 'ITGAX', 'SPP1', 'TCIRG1', 'SLC1A5', 'TNFRSF1B', 'GAL3ST4', 'C1QC']",0.3543654196518801,0,0,10
44,PPAR signaling pathway WP3942,0.03734973214308958,2.785265049415993,9.156362597300063,"['FADS2', 'ACSL1', 'SCD', 'OLR1', 'PLTP', 'PPARD']",0.39471876014856033,0,0,6
45,Nanoparticle triggered autophagic cell death WP2509,0.045673671748169324,2.9821188233032108,9.203514290714907,"['VMP1', 'ATG3', 'MAP1LC3A', 'INSR', 'ATG14']",0.4521673128061943,0,0,5
46,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.045702932692239,5.003758389261745,15.439560911106199,"['CYSLTR1', 'LTC4S', 'PPARD']",0.4521673128061943,0,0,3
47,Overview of nanoparticle effects WP3287,0.045702932692239,5.003758389261745,15.439560911106199,"['CCND3', 'HMOX1', 'BAX']",0.4521673128061943,0,0,3
48,Calcium Regulation in the Cardiac Cell WP536,0.04819124599169185,1.7510675505307252,5.31024874262619,"['CHRM3', 'RYR2', 'CACNA1B', 'CACNA1A', 'CACNA1D', 'CACNA1C', 'RGS4', 'GJA1', 'GNG3', 'CALM3', 'CALR', 'CALM2', 'YWHAG', 'YWHAH']",0.46685269554451475,0,0,14
49,Prostaglandin Synthesis and Regulation WP98,0.054971756039366285,3.3376344086021503,9.682262983708787,"['HPGDS', 'ANXA4', 'S100A6', 'PPARGC1B']",0.4899258264375292,0,0,4
50,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.054971756039366285,3.3376344086021503,9.682262983708787,"['FCGR2A', 'NLRP3', 'TMEM173', 'IKBKE']",0.4899258264375292,0,0,4
51,Allograft Rejection WP2328,0.05719500150367227,2.24976642790408,6.4372314168918,"['C1QB', 'C1QA', 'CXCL12', 'GNLY', 'LRRK2', 'CD55', 'C1QC']",0.4899258264375292,0,0,7
52,Caloric restriction and aging WP4191,0.05962490579533029,8.332439678284182,23.4948294247528,"['NAMPT', 'IGF1']",0.4899258264375292,0,0,2
53,"GPCRs, Class B Secretin-like WP334",0.05962490579533029,8.332439678284182,23.4948294247528,"['ADGRE2', 'ADGRL2']",0.4899258264375292,0,0,2
54,Inflammatory Response Pathway WP453,0.05962490579533029,8.332439678284182,23.4948294247528,"['IL4R', 'TNFRSF1B']",0.4899258264375292,0,0,2
55,PTF1A related regulatory pathway WP4147,0.05962490579533029,8.332439678284182,23.4948294247528,"['NOTCH1', 'RBPJ']",0.4899258264375292,0,0,2
56,MAPK Signaling Pathway WP382,0.06172128361050287,1.5254745254745254,4.248639456389286,"['DUSP3', 'LRRK2', 'CACNA2D3', 'PDGFB', 'CACNA1B', 'CACNA1A', 'CACNA1D', 'CACNA1C', 'RASGRP3', 'RPS6KA5', 'CACNB4', 'FGF14', 'DUSP10', 'GRB2', 'MAP3K8', 'CD14', 'FGF13', 'HSPA1B', 'HSPA1A', 'MAP2K6']",0.4899258264375292,0,0,20
57,LTF danger signal response pathway WP4478,0.0632162356693586,4.169127516778524,11.511770373678717,"['CD14', 'TLR4', 'TLR2']",0.4899258264375292,0,0,3
58,Omega-9 FA synthesis WP4724,0.0632162356693586,4.169127516778524,11.511770373678717,"['FADS2', 'ACSL1', 'SCD']",0.4899258264375292,0,0,3
59,Peptide GPCRs WP24,0.0632162356693586,4.169127516778524,11.511770373678717,"['CX3CR1', 'C5AR1', 'FPR1']",0.4899258264375292,0,0,3
60,Triacylglyceride synthesis WP325,0.0632162356693586,4.169127516778524,11.511770373678717,"['LIPC', 'GK', 'PLPP3']",0.4899258264375292,0,0,3
61,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.06691863632811547,2.608512786002692,7.054143167896404,"['IFNAR2', 'OAS1', 'IKBKE', 'TLR4', 'TLR2']",0.510117473648749,0,0,5
62,Nuclear receptors WP170,0.06881794214719539,3.033724340175953,8.119128483764866,"['ESRRA', 'RORA', 'NR1D2', 'PPARD']",0.5161345661039654,0,0,4
63,Regulation of toll-like receptor signaling pathway WP1449,0.07074211546433112,1.6742857142857144,4.434704330998147,"['IFNAR2', 'LY96', 'TNFAIP3', 'SMAD6', 'IRAK2', 'SPP1', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR4', 'MAP2K6', 'TLR2']",0.522144185570063,0,0,13
64,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.07383895485328085,1.7020081061164334,4.435209894425164,"['RYR2', 'SNAP25', 'GJA1', 'CEBPB', 'BHLHE40', 'RORA', 'YBX1', 'HIF1A', 'PPARGC1B', 'YWHAG', 'HSP90B1', 'YWHAH']",0.5364861563558686,0,0,12
65,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.07928061412528757,2.454675005937772,6.222016050364528,"['IRAK2', 'LY96', 'PLAT', 'CD14', 'TLR4']",0.5612935579993515,0,0,5
66,Toll-like Receptor Signaling Pathway WP75,0.07966747274829505,1.7791039612523785,4.500944254751457,"['IFNAR2', 'SPP1', 'LY96', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR4', 'MAP2K6', 'TLR2']",0.5612935579993515,0,0,10
67,Cardiac Progenitor Differentiation WP2406,0.08332207399367741,3.5729626078619368,8.878961326730602,"['NOTCH1', 'NRG1', 'IGF1']",0.5643903178916787,0,0,3
68,IL1 and megakaryocytes in obesity WP2865,0.08332207399367741,3.5729626078619368,8.878961326730602,"['NLRP3', 'PLA2G7', 'TLR2']",0.5643903178916787,0,0,3
69,Acute viral myocarditis WP4298,0.08394668345428635,1.9098069498069499,4.731686902639899,"['STAT3', 'CASP1', 'CYCS', 'BAX', 'TLR5', 'TLR4', 'AIF1', 'CD55']",0.5643903178916787,0,0,8
70,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.09241404686484182,5.554066130473637,13.226876800270981,"['CASP1', 'NLRP3']",0.5643903178916787,0,0,2
71,HIF1A and PPARG regulation of glycolysis WP2456,0.09241404686484182,5.554066130473637,13.226876800270981,"['TPI1', 'HIF1A']",0.5643903178916787,0,0,2
72,Insulin signaling in adipocytes (diabetic condition) WP3635,0.09241404686484182,5.554066130473637,13.226876800270981,"['TBC1D4', 'INSR']",0.5643903178916787,0,0,2
73,Insulin signaling in adipocytes (normal condition) WP3634,0.09241404686484182,5.554066130473637,13.226876800270981,"['TBC1D4', 'INSR']",0.5643903178916787,0,0,2
74,Nanomaterial-induced inflammasome activation WP3890,0.09241404686484182,5.554066130473637,13.226876800270981,"['CASP1', 'TLR4']",0.5643903178916787,0,0,2
75,NOTCH1 regulation of endothelial cell calcification WP3413,0.09241404686484182,5.554066130473637,13.226876800270981,"['NOTCH1', 'PLAT']",0.5643903178916787,0,0,2
76,Apoptosis Modulation and Signaling WP1772,0.0934581816723855,1.8564564564564565,4.40024957460011,"['CAPNS1', 'CASP4', 'CASP1', 'CYCS', 'BAX', 'TNFRSF1B', 'TNFRSF10D', 'HSPA1A']",0.5643903178916787,0,0,8
77,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.0934581816723855,1.8564564564564565,4.40024957460011,"['NHSL1', 'NOTCH1', 'TG', 'TBC1D4', 'ITGAV', 'GRB2', 'TTF2', 'MGLL']",0.5643903178916787,0,0,8
78,Neovascularisation processes WP4331,0.10125865508965667,2.566170388751034,5.876728027303269,"['NOTCH1', 'CXCL12', 'PDGFB', 'HIF1A']",0.578601404466402,0,0,4
79,ESC Pluripotency Pathways WP3931,0.10355994919592436,1.8059897735573411,4.095270744574779,"['FGF14', 'WNT5A', 'STAT3', 'PDGFB', 'GRB2', 'SMAD6', 'FGF13', 'MAP2K6']",0.578601404466402,0,0,8
80,Gastric Cancer Network 2 WP2363,0.10576266615561897,3.1258389261744965,7.022377488885909,"['PLAC8', 'RNF144B', 'S100A6']",0.578601404466402,0,0,3
81,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.10576266615561897,3.1258389261744965,7.022377488885909,"['IL4R', 'STAT3', 'TLR4']",0.578601404466402,0,0,3
82,Type II diabetes mellitus WP1584,0.10576266615561897,3.1258389261744965,7.022377488885909,"['GK', 'INSR', 'CACNA1A']",0.578601404466402,0,0,3
83,Disruption of postsynaptic signaling by CNV WP4875,0.10735813802166186,2.195579797407381,4.89962283071576,"['RYR2', 'DLGAP1', 'GRIN2B', 'YWHAG', 'STX1A']",0.578601404466402,0,0,5
84,"COVID-19, thrombosis and anticoagulation WP4927",0.10737844158013017,inf,inf,['F13A1'],0.578601404466402,0,0,1
85,SCFA and skeletal muscle substrate metabolism WP4030,0.10737844158013017,inf,inf,['PPARD'],0.578601404466402,0,0,1
86,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.10737844158013017,inf,inf,['HRH2'],0.578601404466402,0,0,1
87,Selenium Micronutrient Network WP15,0.10825445631952035,2.0031266846361184,4.453492958529314,"['SELENOM', 'PRDX5', 'INSR', 'SELENOW', 'PLAT', 'SELENOH']",0.578601404466402,0,0,6
88,7q11.23 copy number variation syndrome WP4932,0.11363828729958929,1.6385036399383601,3.5633108748718425,"['GRIP1', 'SNAP25', 'VPS9D1', 'ATP5MC3', 'DDX21', 'GRB2', 'NRG1', 'STX1A', 'ATP5F1E', 'ATP5MC1']",0.596890278194421,0,0,10
89,Non-small cell lung cancer WP4255,0.1142435156114053,1.7581792318634424,3.814234475955038,"['CDKN1A', 'STAT3', 'CYCS', 'BAX', 'E2F3', 'GRB2', 'JAK3', 'PDK1']",0.596890278194421,0,0,8
90,Synaptic Vesicle Pathway WP2267,0.1185501555587832,1.826163967611336,3.8941470234139275,"['SNAP25', 'RAB3A', 'CACNA1B', 'CACNA1A', 'SYN3', 'CPLX1', 'STX1A']",0.5996755953545302,0,0,7
91,Fatty acid beta-oxidation WP143,0.1196756591994589,2.3824884792626726,5.057951651331292,"['LIPC', 'TPI1', 'GK', 'ACSL1']",0.5996755953545302,0,0,4
92,Alzheimer's disease WP2059,0.12549712731180634,1.7128205128205127,3.554911718699623,"['ATP5MD', 'VMP1', 'CYCS', 'CACNA1D', 'CALM3', 'CACNA1C', 'GRIN2B', 'CALM2']",0.5996755953545302,0,0,8
93,Oxidative phosphorylation WP623,0.12549712731180634,1.7128205128205127,3.554911718699623,"['NDUFB10', 'NDUFS6', 'NDUFA4', 'NDUFA3', 'ATP5MC3', 'ATP5MF', 'ATP5F1E', 'ATP5MC1']",0.5996755953545302,0,0,8
94,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.12900803512294262,4.164879356568365,8.529175588949876,"['TLR4', 'TLR2']",0.5996755953545302,0,0,2
95,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.12900803512294262,4.164879356568365,8.529175588949876,"['GRM5', 'GRM7']",0.5996755953545302,0,0,2
96,Kynurenine Pathway and links to Cellular Senescence WP5044,0.12900803512294262,4.164879356568365,8.529175588949876,"['CDKN1A', 'TLR4']",0.5996755953545302,0,0,2
97,Osteoclast Signaling WP12,0.12900803512294262,4.164879356568365,8.529175588949876,"['PDGFB', 'SPP1']",0.5996755953545302,0,0,2
98,Transcriptional cascade regulating adipogenesis WP4211,0.12900803512294262,4.164879356568365,8.529175588949876,"['CEBPB', 'CEBPD']",0.5996755953545302,0,0,2
99,Urea cycle and metabolism of amino groups WP497,0.12900803512294262,4.164879356568365,8.529175588949876,"['OAT', 'SRM']",0.5996755953545302,0,0,2
100,Monoamine Transport WP727,0.13025211856087646,2.778076062639821,5.66250613666927,"['SLC6A1', 'NECTIN2', 'STX1A']",0.5996755953545302,0,0,3
101,Statin inhibition of cholesterol production WP430,0.13025211856087646,2.778076062639821,5.66250613666927,"['LIPC', 'APOC1', 'PLTP']",0.5996755953545302,0,0,3
102,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.13940953079599933,2.2232974910394265,4.3806506731160155,"['ANGPT2', 'BAX', 'SLC2A3', 'HIF1A']",0.6355434492170557,0,0,4
103,Notch Signaling Pathway Netpath WP61,0.1513020367254788,1.787639584135541,3.3759165906922006,"['CDKN1A', 'NOTCH1', 'STAT3', 'RBPJ', 'HIF1A', 'SAP30']",0.6817605336161748,0,0,6
104,IL-9 signaling pathway WP22,0.1564911249426934,2.4998657718120807,4.636640990069073,"['STAT3', 'GRB2', 'JAK3']",0.6817605336161748,0,0,3
105,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.1564911249426934,2.4998657718120807,4.636640990069073,"['TLR5', 'TLR4', 'TLR2']",0.6817605336161748,0,0,3
106,Transcription factor regulation in adipogenesis WP3599,0.1564911249426934,2.4998657718120807,4.636640990069073,"['CEBPB', 'CEBPD', 'INSR']",0.6817605336161748,0,0,3
107,CAMKK2  Pathway WP4874,0.15713391480536285,1.8952648966107917,3.5074850139941463,"['HDAC4', 'CHRM3', 'MAP1LC3A', 'HMOX1', 'CALM2']",0.6817605336161748,0,0,5
108,Pathogenic Escherichia coli infection WP2272,0.1583443820011761,1.668825910931174,3.0756177587568096,"['TUBB3', 'NCK2', 'LY96', 'CD14', 'TLR5', 'TLR4', 'ACTG1']",0.6817605336161748,0,0,7
109,Toll-like Receptor Signaling related to MyD88 WP3858,0.16033380830805025,2.084005376344086,3.8147662877915285,"['TLR5', 'IKBKE', 'TLR4', 'TLR2']",0.6839928519563612,0,0,4
110,7-oxo-C and 7beta-HC pathways WP5064,0.1682140875979896,3.331367292225201,5.938221429798695,"['DBP', 'ACOT7']",0.7046806372348213,0,0,2
111,Nanomaterial induced apoptosis WP2507,0.1682140875979896,3.331367292225201,5.938221429798695,"['BAX', 'CYCS']",0.7046806372348213,0,0,2
112,Regulatory circuits of the STAT3 signaling pathway WP4538,0.18361186657730766,1.6679245283018869,2.827017272410467,"['PTPRT', 'IFNAR2', 'IL10RB', 'STAT3', 'JAK3', 'CSF2RA']",0.7364301889036386,0,0,6
113,NRF2-ARE regulation WP4357,0.18417823336901046,2.2722391702257476,3.844290863603648,"['CEBPB', 'INSR', 'HMOX1']",0.7364301889036386,0,0,3
114,White fat cell differentiation WP4149,0.18417823336901046,2.2722391702257476,3.844290863603648,"['CEBPB', 'CEBPD', 'RORA']",0.7364301889036386,0,0,3
115,Regulation of Actin Cytoskeleton WP51,0.1863762025926418,1.3917572463768115,2.338135547111649,"['CHRM3', 'FGF14', 'TMSB4X', 'PXN', 'PDGFB', 'IQGAP1', 'CD14', 'PFN1', 'SSH2', 'FGF13', 'DOCK1', 'ACTG1']",0.7364301889036386,0,0,12
116,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.1946570154729131,1.7367653656348139,2.842244594112427,"['CDKN1A', 'CEBPB', 'NOTCH1', 'CEBPD', 'SPP1']",0.7364301889036386,0,0,5
117,Blood Clotting Cascade WP272,0.20324061119819592,8.322623828647925,13.260975227911954,['PLAT'],0.7364301889036386,0,0,1
118,Dopaminergic Neurogenesis WP2855,0.20324061119819592,8.322623828647925,13.260975227911954,['STAT3'],0.7364301889036386,0,0,1
119,Gene regulatory network modelling somitogenesis  WP2854,0.20324061119819592,8.322623828647925,13.260975227911954,['NOTCH1'],0.7364301889036386,0,0,1
120,Hfe effect on hepcidin production WP3924,0.20324061119819592,8.322623828647925,13.260975227911954,['HAMP'],0.7364301889036386,0,0,1
121,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.20324061119819592,8.322623828647925,13.260975227911954,['NOTCH1'],0.7364301889036386,0,0,1
122,Thyroxine (Thyroid Hormone) Production WP1981,0.20324061119819592,8.322623828647925,13.260975227911954,['TG'],0.7364301889036386,0,0,1
123,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.20396110974991352,1.483003003003003,2.3577166459304464,"['HDAC4', 'WNT5A', 'STAT3', 'NRG1', 'IGF1', 'IKBKE', 'CALM2', 'MAP2K6']",0.7364301889036386,0,0,8
124,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.20521013292823398,1.8518518518518519,2.932816270671908,"['HSP90AA1', 'CASP1', 'NLRP3', 'NLRP1']",0.7364301889036386,0,0,4
125,Cori Cycle WP1946,0.20905115039845223,2.7756925826630923,4.344448297022066,"['TPI1', 'PGAM1']",0.7364301889036386,0,0,2
126,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.20905115039845223,2.7756925826630923,4.344448297022066,"['RAB27A', 'UNC13D']",0.7364301889036386,0,0,2
127,Fluoropyrimidine Activity WP1601,0.20905115039845223,2.7756925826630923,4.344448297022066,"['DPYD', 'TYMP']",0.7364301889036386,0,0,2
128,"NAD metabolism, sirtuins and aging WP3630",0.20905115039845223,2.7756925826630923,4.344448297022066,"['NAMPT', 'HIF1A']",0.7364301889036386,0,0,2
129,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.20905115039845223,2.7756925826630923,4.344448297022066,"['STAT3', 'JAK3']",0.7364301889036386,0,0,2
130,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.20905115039845223,2.7756925826630923,4.344448297022066,"['PDGFB', 'IGF1']",0.7364301889036386,0,0,2
131,Omega-3/Omega-6 FA synthesis WP4723,0.20905115039845223,2.7756925826630923,4.344448297022066,"['FADS2', 'ACSL1']",0.7364301889036386,0,0,2
132,Proteoglycan biosynthesis WP4784,0.20905115039845223,2.7756925826630923,4.344448297022066,"['CSGALNACT1', 'CHSY1']",0.7364301889036386,0,0,2
133,Immune response to tuberculosis WP4197,0.21301831111081287,2.08255033557047,3.220408251216798,"['IFNAR2', 'OAS1', 'PTPN2']",0.7447632681693834,0,0,3
134,Neural Crest Differentiation WP2064,0.22888110029709044,1.754102999434069,2.5865171787258223,"['HDAC4', 'NOTCH1', 'RBPJ', 'RHOB']",0.7750085134298708,0,0,4
135,DNA damage response (only ATM dependent) WP710,0.23083967065294275,1.3901668921966621,2.0380289767442217,"['CCND3', 'CDKN1A', 'MLKL', 'BCL6', 'INSR', 'WNT5A', 'BAX', 'GRB2', 'PDK1']",0.7750085134298708,0,0,9
136,TNF-alpha signaling pathway WP231,0.23083967065294275,1.3901668921966621,2.0380289767442217,"['HSP90AA1', 'TNFAIP3', 'BAX', 'MAP3K8', 'GRB2', 'PYGL', 'KSR2', 'TNFRSF1B', 'MAP2K6']",0.7750085134298708,0,0,9
137,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.23576022288549164,1.4590418353576249,2.108227902522336,"['HSPA5', 'TUBB3', 'PSMD5', 'CASP1', 'STUB1', 'HSPA1B', 'HSPA1A']",0.7750085134298708,0,0,7
138,3q29 copy number variation syndrome WP4906,0.2365017509860267,1.515559911786327,2.1851337766339443,"['DYNLT3', 'PXN', 'SLC40A1', 'DYNLL1', 'HIF1A', 'HAMP']",0.7750085134298708,0,0,6
139,Bladder cancer WP2828,0.24272873560208613,1.9220443985544657,2.721251166771158,"['CDKN1A', 'RPS6KA5', 'TYMP']",0.7750085134298708,0,0,3
140,Unfolded protein response WP4925,0.24272873560208613,1.9220443985544657,2.721251166771158,"['XBP1', 'HSPA5', 'TXNIP']",0.7750085134298708,0,0,3
141,IL-18 signaling pathway WP4754,0.24383354652738454,1.248352995250498,1.7617624735342803,"['CEBPB', 'NRN1', 'CD83', 'TNFAIP2', 'TNFAIP3', 'PLA2G7', 'GRIN2B', 'GRM7', 'TMSB4X', 'SPP1', 'HMOX1', 'CYCS', 'BAX', 'KIFC3', 'RPS11', 'CDK5R2']",0.7750085134298708,0,0,16
142,Senescence and Autophagy in Cancer WP615,0.24910082027458283,1.3896396396396395,1.9314567496484394,"['ATG3', 'GABARAPL1', 'CDKN1A', 'CEBPB', 'MAP1LC3A', 'PLAT', 'IGF1', 'ATG14']",0.7750085134298708,0,0,8
143,Leptin Insulin Overlap WP3935,0.2507182733798306,2.3787820758330143,3.2908675139556465,"['INSR', 'STAT3']",0.7750085134298708,0,0,2
144,miRNAs involved in DNA damage response WP1545,0.2507182733798306,2.3787820758330143,3.2908675139556465,"['CDKN1A', 'CCND3']",0.7750085134298708,0,0,2
145,Osteopontin Signaling WP1434,0.2507182733798306,2.3787820758330143,3.2908675139556465,"['SPP1', 'ITGAV']",0.7750085134298708,0,0,2
146,Oxysterols derived from cholesterol WP4545,0.2507182733798306,2.3787820758330143,3.2908675139556465,"['DBP', 'ACOT7']",0.7750085134298708,0,0,2
147,Phytochemical activity on NRF2 transcriptional activation WP3,0.2507182733798306,2.3787820758330143,3.2908675139556465,"['CEBPB', 'HMOX1']",0.7750085134298708,0,0,2
148,TP53 network WP1742,0.2507182733798306,2.3787820758330143,3.2908675139556465,"['CDKN1A', 'BAX']",0.7750085134298708,0,0,2
149,Hepatitis C and Hepatocellular Carcinoma WP3646,0.25318569319092943,1.6661290322580644,2.288648311944342,"['CDKN1A', 'STAT3', 'GRB2', 'HIF1A']",0.7750085134298708,0,0,4
150,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.25318569319092943,1.6661290322580644,2.288648311944342,"['CDKN1A', 'HSP90AA1', 'BAX', 'MAP2K6']",0.7750085134298708,0,0,4
151,Apoptosis WP254,0.274051960846,1.4284944166345783,1.8490968163555477,"['CASP4', 'CASP1', 'CYCS', 'BAX', 'IGF1', 'TNFRSF1B']",0.7750085134298708,0,0,6
152,Cardiac Hypertrophic Response WP2795,0.274051960846,1.4284944166345783,1.8490968163555477,"['HDAC4', 'NRG1', 'IGF1', 'IKBKE', 'CALM2', 'MAP2K6']",0.7750085134298708,0,0,6
153,Melanoma WP4685,0.274051960846,1.4284944166345783,1.8490968163555477,"['CDKN1A', 'BAX', 'E2F3', 'CALM3', 'GRB2', 'CALM2']",0.7750085134298708,0,0,6
154,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.27722856601877827,1.4876946741011343,1.9085827853064188,"['BEX3', 'CDKN1A', 'HSPA5', 'NRG1', 'YBX3']",0.7750085134298708,0,0,5
155,Glycolysis and Gluconeogenesis WP534,0.27798544227262867,1.5865335381464414,2.031058869034961,"['TPI1', 'PGAM1', 'SLC2A3', 'SLC2A5']",0.7750085134298708,0,0,4
156,NO/cGMP/PKG mediated Neuroprotection WP4008,0.27798544227262867,1.5865335381464414,2.031058869034961,"['TSPO', 'CYCS', 'GRIN2B', 'CALM2']",0.7750085134298708,0,0,4
157,Myometrial relaxation and contraction pathways WP289,0.288604567525065,1.2563892864444899,1.56131221009503,"['RGS4', 'RYR2', 'GJA1', 'GNG3', 'PDE4D', 'PDE4B', 'CALM3', 'CALM2', 'YWHAG', 'ACTG1', 'YWHAH']",0.7750085134298708,0,0,11
158,Cellular Proteostasis WP4918,0.2888200560172506,4.160642570281125,5.167315982937983,['PFDN5'],0.7750085134298708,0,0,1
159,EV release from cardiac cells and their functional effects WP3297,0.2888200560172506,4.160642570281125,5.167315982937983,['CXCL12'],0.7750085134298708,0,0,1
160,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.2888200560172506,4.160642570281125,5.167315982937983,['CEBPB'],0.7750085134298708,0,0,1
161,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.2888200560172506,4.160642570281125,5.167315982937983,['FADS2'],0.7750085134298708,0,0,1
162,Liver X receptor pathway WP2874,0.2888200560172506,4.160642570281125,5.167315982937983,['SCD'],0.7750085134298708,0,0,1
163,Metabolism of alpha-linolenic acid WP4586,0.2888200560172506,4.160642570281125,5.167315982937983,['FADS2'],0.7750085134298708,0,0,1
164,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.2888200560172506,4.160642570281125,5.167315982937983,['HIF1A'],0.7750085134298708,0,0,1
165,miR-517 relationship with ARCN1 and USP1 WP3596,0.2888200560172506,4.160642570281125,5.167315982937983,['CDKN1A'],0.7750085134298708,0,0,1
166,Peroxiredoxin 2 induced ovarian failure WP4873,0.2888200560172506,4.160642570281125,5.167315982937983,['BAX'],0.7750085134298708,0,0,1
167,Sulfation Biotransformation Reaction WP692,0.2888200560172506,4.160642570281125,5.167315982937983,['SULT4A1'],0.7750085134298708,0,0,1
168,Apoptosis Modulation by HSP70 WP384,0.2925673222322836,2.081099195710456,2.557796770820635,"['CYCS', 'HSPA1A']",0.7750085134298708,0,0,2
169,Canonical and non-canonical Notch signaling WP3845,0.2925673222322836,2.081099195710456,2.557796770820635,"['NOTCH1', 'RBPJ']",0.7750085134298708,0,0,2
170,Development of ureteric collection system WP5053,0.2925673222322836,2.081099195710456,2.557796770820635,"['ROBO2', 'GRIP1']",0.7750085134298708,0,0,2
171,Nucleotide metabolism WP404,0.2925673222322836,2.081099195710456,2.557796770820635,"['OAZ1', 'SRM']",0.7750085134298708,0,0,2
172,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.2925673222322836,2.081099195710456,2.557796770820635,"['OAS1', 'TMEM173']",0.7750085134298708,0,0,2
173,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.2925673222322836,2.081099195710456,2.557796770820635,"['HMGCS1', 'SCD']",0.7750085134298708,0,0,2
174,Vitamin B12 metabolism WP1533,0.2925673222322836,2.081099195710456,2.557796770820635,"['INSR', 'PLAT']",0.7750085134298708,0,0,2
175,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.2925673222322836,2.081099195710456,2.557796770820635,"['ZBTB16', 'PPARD']",0.7750085134298708,0,0,2
176,Oncostatin M Signaling Pathway WP2374,0.29333655562076827,1.3885893980233603,1.7030141873058546,"['CEBPB', 'PXN', 'STAT3', 'GRB2', 'JAK3', 'HIF1A']",0.7750085134298708,0,0,6
177,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.3031462214850023,1.5141739980449658,1.8072272498558364,"['FADS2', 'HMGCS1', 'ACSL1', 'SCD']",0.7786979205935047,0,0,4
178,Phosphodiesterases in neuronal function WP4222,0.3031462214850023,1.5141739980449658,1.8072272498558364,"['PDE4D', 'PDE4B', 'PDE5A', 'GRIN2B']",0.7786979205935047,0,0,4
179,Aryl Hydrocarbon Receptor Pathway WP2873,0.30371736865207705,1.665234899328859,1.9843900207411622,"['SLC7A5', 'HSP90AA1', 'BAX']",0.7786979205935047,0,0,3
180,EPO Receptor Signaling WP581,0.30371736865207705,1.665234899328859,1.9843900207411622,"['STAT3', 'GRB2', 'PDK1']",0.7786979205935047,0,0,3
181,IL17 signaling pathway WP2112,0.30371736865207705,1.665234899328859,1.9843900207411622,"['CEBPB', 'CEBPD', 'STAT3']",0.7786979205935047,0,0,3
182,Ectoderm Differentiation WP2858,0.3047806915011137,1.2713240522006377,1.5105399522695269,"['PLCXD3', 'ZBTB16', 'PIM1', 'SORCS1', 'LDB2', 'KIFC3', 'CDH8', 'ASTN1', 'PPARD']",0.7786979205935047,0,0,9
183,IL-4 signaling pathway WP395,0.32090895951528375,1.3880663974876626,1.577673229317595,"['CEBPB', 'IL4R', 'STAT3', 'GRB2', 'JAK3']",0.8066090063492267,0,0,5
184,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.32090895951528375,1.3880663974876626,1.577673229317595,"['KIRREL3', 'CDKN1A', 'NOTCH1', 'ITGAV', 'TLR4']",0.8066090063492267,0,0,5
185,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.32090895951528375,1.3880663974876626,1.577673229317595,"['ANGPT2', 'PXN', 'STAT3', 'BAX', 'GRB2']",0.8066090063492267,0,0,5
186,MECP2 and Associated Rett Syndrome WP3584,0.33262731094580555,1.3150801532132217,1.4475515990261212,"['RBFOX1', 'CEBPD', 'BCL6', 'YBX1', 'IGF1', 'FKBP5']",0.8144197058262428,0,0,6
187,Angiogenesis WP1539,0.3340794624494852,1.8495680667262437,2.0278227836875877,"['PDGFB', 'HIF1A']",0.8144197058262428,0,0,2
188,Mitochondrial Gene Expression WP391,0.3340794624494852,1.8495680667262437,2.0278227836875877,"['ESRRA', 'PPARGC1B']",0.8144197058262428,0,0,2
189,Pre-implantation embryo WP3527,0.3340794624494852,1.8495680667262437,2.0278227836875877,"['ESRRA', 'ZFP36']",0.8144197058262428,0,0,2
190,Signal transduction through IL1R WP4496,0.3345250834684137,1.5609060402684565,1.7092598797025436,"['IRAK2', 'IL1RAP', 'MAP2K6']",0.8144197058262428,0,0,3
191,The influence of laminopathies on Wnt signaling WP4844,0.3345250834684137,1.5609060402684565,1.7092598797025436,"['CEBPB', 'CEBPD', 'SPP1']",0.8144197058262428,0,0,3
192,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.34305364797515525,1.3430729822428689,1.436911390886718,"['CDKN1A', 'TMSB4X', 'GRB2', 'PFN1', 'PFN2']",0.8183234209117995,0,0,5
193,Cysteine and methionine catabolism WP4504,0.36521842548915723,2.7733154841588576,2.7934488626406173,['SQOR'],0.8183234209117995,0,0,1
194,Farnesoid X receptor pathway WP2879,0.36521842548915723,2.7733154841588576,2.7934488626406173,['FKBP5'],0.8183234209117995,0,0,1
195,Glutathione metabolism WP100,0.36521842548915723,2.7733154841588576,2.7934488626406173,['IDH1'],0.8183234209117995,0,0,1
196,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.36521842548915723,2.7733154841588576,2.7934488626406173,['LIPC'],0.8183234209117995,0,0,1
197,Metastatic brain tumor WP2249,0.36521842548915723,2.7733154841588576,2.7934488626406173,['E2F3'],0.8183234209117995,0,0,1
198,Mevalonate pathway WP3963,0.36521842548915723,2.7733154841588576,2.7934488626406173,['HMGCS1'],0.8183234209117995,0,0,1
199,Role of Osx and miRNAs in tooth development WP3971,0.36521842548915723,2.7733154841588576,2.7934488626406173,['NOTCH1'],0.8183234209117995,0,0,1
200,Serotonin Transporter Activity WP1455,0.36521842548915723,2.7733154841588576,2.7934488626406173,['STX1A'],0.8183234209117995,0,0,1
201,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.36521842548915723,2.7733154841588576,2.7934488626406173,['STAT3'],0.8183234209117995,0,0,1
202,Thiamine metabolic pathways WP4297,0.36521842548915723,2.7733154841588576,2.7934488626406173,['SLC25A19'],0.8183234209117995,0,0,1
203,Parkinson's disease pathway WP2371,0.3652647135568433,1.4688511646269247,1.4793284001367286,"['PINK1', 'LRRK2', 'CYCS']",0.8183234209117995,0,0,3
204,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3652647135568433,1.4688511646269247,1.4793284001367286,"['CALM3', 'CALM2', 'CREB5']",0.8183234209117995,0,0,3
205,Exercise-induced Circadian Regulation WP410,0.36529539963119173,1.300891655450875,1.3100615609329573,"['CEBPB', 'TUBB3', 'NR1D2', 'ERC2', 'ARNTL']",0.8183234209117995,0,0,5
206,Mitochondrial complex I assembly model OXPHOS system WP4324,0.36529539963119173,1.300891655450875,1.3100615609329573,"['NDUFB10', 'NDUFS6', 'NDUFA3', 'NDUFB3', 'NDUFA1']",0.8183234209117995,0,0,5
207,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.36529539963119173,1.300891655450875,1.3100615609329573,"['RPS6KA5', 'IRAK2', 'MAP3K8', 'IL1RAP', 'MAP2K6']",0.8183234209117995,0,0,5
208,Fatty Acid Biosynthesis WP357,0.37484492183701784,1.664343163538874,1.6331248796178999,"['ACSL1', 'SCD']",0.8183234209117995,0,0,2
209,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.37484492183701784,1.664343163538874,1.6331248796178999,"['HIF1A', 'PDK1']",0.8183234209117995,0,0,2
210,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.37484492183701784,1.664343163538874,1.6331248796178999,"['PXN', 'ITGAV']",0.8183234209117995,0,0,2
211,PKC-gamma calcium signaling pathway in ataxia WP4760,0.37484492183701784,1.664343163538874,1.6331248796178999,"['CACNA1A', 'PDK1']",0.8183234209117995,0,0,2
212,Purinergic signaling WP4900,0.37484492183701784,1.664343163538874,1.6331248796178999,"['P2RY12', 'P2RY13']",0.8183234209117995,0,0,2
213,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.37484492183701784,1.664343163538874,1.6331248796178999,"['P4HA1', 'P3H2']",0.8183234209117995,0,0,2
214,Signaling of Hepatocyte Growth Factor Receptor WP313,0.3795462150087163,1.3318279569892473,1.2902468376539484,"['PXN', 'STAT3', 'GRB2', 'DOCK1']",0.8247149064441733,0,0,4
215,Retinoblastoma gene in cancer WP2446,0.38755903761690075,1.2612667727068805,1.195538486673624,"['CDKN1A', 'CCND3', 'H2AFZ', 'E2F3', 'SAP30']",0.838209081357483,0,0,5
216,Integrin-mediated Cell Adhesion WP185,0.3957034324369172,1.1893194524773472,1.1026064760042391,"['CAPNS1', 'PXN', 'ITGAX', 'GRB2', 'ITGAV', 'DOCK1', 'MAP2K6']",0.8397502735054355,0,0,7
217,Melatonin metabolism and effects WP3298,0.3957565150024006,1.3870246085011186,1.2857109465797198,"['PER3', 'CALM2', 'ARNTL']",0.8397502735054355,0,0,3
218,Hepatitis B infection WP4666,0.4005796305426872,1.130827344757693,1.03452914630503,"['CDKN1A', 'STAT3', 'CYCS', 'BAX', 'GRB2', 'IKBKE', 'JAK3', 'TLR4', 'MAP2K6', 'CREB5', 'TLR2']",0.8397502735054355,0,0,11
219,Microglia Pathogen Phagocytosis Pathway WP3937,0.40494000252752926,1.2803970223325063,1.1574998615747571,"['C1QB', 'C1QA', 'FCER1G', 'C1QC']",0.8397502735054355,0,0,4
220,Small cell lung cancer WP4658,0.40977333792107096,1.223972765418415,1.0919686569839668,"['CDKN1A', 'CYCS', 'BAX', 'ITGAV', 'E2F3']",0.8397502735054355,0,0,5
221,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.40977333792107096,1.223972765418415,1.0919686569839668,"['EIF4A2', 'RPS6KA5', 'PIM1', 'PDK1', 'MAP2K6']",0.8397502735054355,0,0,5
222,Breast cancer pathway WP4262,0.4140268454785329,1.1653441295546558,1.0276289613806733,"['CDKN1A', 'NOTCH1', 'WNT5A', 'BAX', 'GRB2', 'E2F3', 'IGF1']",0.8397502735054355,0,0,7
223,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.41454559967116233,1.5127955154764807,1.3321258252647121,"['BCL6', 'H2AFZ']",0.8397502735054355,0,0,2
224,Folate Metabolism WP176,0.41454559967116233,1.5127955154764807,1.3321258252647121,"['INSR', 'PLAT']",0.8397502735054355,0,0,2
225,Heart Development WP1591,0.41454559967116233,1.5127955154764807,1.3321258252647121,"['NOTCH1', 'BHLHE40']",0.8397502735054355,0,0,2
226,SARS coronavirus and innate immunity WP4912,0.41454559967116233,1.5127955154764807,1.3321258252647121,"['IFNAR2', 'IKBKE']",0.8397502735054355,0,0,2
227,Sphingolipid Metabolism (general overview) WP4725,0.41454559967116233,1.5127955154764807,1.3321258252647121,"['UGCG', 'PLPP3']",0.8397502735054355,0,0,2
228,Hematopoietic Stem Cell Differentiation WP2849,0.425842775715796,1.3138113740727657,1.1215811573724326,"['NOTCH1', 'PIM1', 'RUNX1']",0.8397502735054355,0,0,3
229,Prion disease pathway WP3995,0.425842775715796,1.3138113740727657,1.1215811573724326,"['HSPA5', 'STAT3', 'HSP90B1']",0.8397502735054355,0,0,3
230,Type 2 papillary renal cell carcinoma WP4241,0.425842775715796,1.3138113740727657,1.1215811573724326,"['CDKN1A', 'PDGFB', 'HIF1A']",0.8397502735054355,0,0,3
231,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.43012876520888305,1.2327757865392275,1.040056762876518,"['ATG3', 'MAP1LC3A', 'ATG14', 'FTL']",0.8397502735054355,0,0,4
232,p53 transcriptional gene network WP4963,0.43012876520888305,1.2327757865392275,1.040056762876518,"['CDKN1A', 'NOTCH1', 'BAX', 'TNFRSF10D']",0.8397502735054355,0,0,4
233,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.43341949600280544,2.0796519410977243,1.738691356266691,['NOTCH1'],0.8397502735054355,0,0,1
234,Cell Differentiation - Index WP2029,0.43341949600280544,2.0796519410977243,1.738691356266691,['STAT3'],0.8397502735054355,0,0,1
235,Cells and molecules involved in local acute inflammatory response  WP4493,0.43341949600280544,2.0796519410977243,1.738691356266691,['SELPLG'],0.8397502735054355,0,0,1
236,GDNF/RET signaling axis WP4830,0.43341949600280544,2.0796519410977243,1.738691356266691,['ROBO2'],0.8397502735054355,0,0,1
237,Hedgehog Signaling Pathway Netpath WP47,0.43341949600280544,2.0796519410977243,1.738691356266691,['ARNTL'],0.8397502735054355,0,0,1
238,NAD+ metabolism WP3644,0.43341949600280544,2.0796519410977243,1.738691356266691,['NAMPT'],0.8397502735054355,0,0,1
239,TCA cycle in senescence WP5050,0.43341949600280544,2.0796519410977243,1.738691356266691,['PDK1'],0.8397502735054355,0,0,1
240,Tryptophan catabolism leading to NAD+ production WP4210,0.43341949600280544,2.0796519410977243,1.738691356266691,['NAMPT'],0.8397502735054355,0,0,1
241,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.45222111045459296,1.134648370497427,0.900438833684766,"['STAT3', 'PDGFB', 'BAX', 'NRG1', 'GRB2', 'IGF1']",0.8544621471768934,0,0,6
242,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.45222111045459296,1.134648370497427,0.900438833684766,"['CCND3', 'PDE4D', 'APEX1', 'STAT3', 'TTF2', 'MAP2K6']",0.8544621471768934,0,0,6
243,Sphingolipid Metabolism (integrated pathway) WP4726,0.45294014555670375,1.3865058087578195,1.098106071816996,"['UGCG', 'PLPP3']",0.8544621471768934,0,0,2
244,Aryl Hydrocarbon Receptor Netpath WP2586,0.45538701540814264,1.2479194630872483,0.9816229815947223,"['CDKN1A', 'HPGDS', 'HSP90AA1']",0.8544621471768934,0,0,3
245,Integrated Cancer Pathway WP1971,0.45538701540814264,1.2479194630872483,0.9816229815947223,"['CDKN1A', 'BAX', 'BACH1']",0.8544621471768934,0,0,3
246,Vitamin D-sensitive calcium signaling in depression WP4698,0.45538701540814264,1.2479194630872483,0.9816229815947223,"['GRM5', 'CACNA1C', 'GRIN2B']",0.8544621471768934,0,0,3
247,Hippo-Merlin Signaling Dysregulation WP4541,0.4718662908036007,1.1092542677448338,0.8331160840730006,"['INSR', 'ITGAX', 'CDH12', 'ITGAV', 'CDH8', 'CDH18']",0.8544621471768934,0,0,6
248,DNA damage response WP707,0.47954805897542935,1.1473859844271412,0.843226767550792,"['CDKN1A', 'CCND3', 'CYCS', 'BAX']",0.8544621471768934,0,0,4
249,G13 Signaling Pathway WP524,0.47954805897542935,1.1473859844271412,0.843226767550792,"['IQGAP1', 'IQGAP2', 'PFN1', 'CALM2']",0.8544621471768934,0,0,4
250,miRNA regulation of DNA damage response WP1530,0.47954805897542935,1.1473859844271412,0.843226767550792,"['CDKN1A', 'CCND3', 'CYCS', 'BAX']",0.8544621471768934,0,0,4
251,Pyrimidine metabolism WP4022,0.47954805897542935,1.1473859844271412,0.843226767550792,"['NT5C', 'DPYD', 'ENPP1', 'TYMP']",0.8544621471768934,0,0,4
252,Glycogen Synthesis and Degradation WP500,0.484272905626578,1.1883029721955896,0.8616464189286752,"['CALM3', 'PYGL', 'CALM2']",0.8544621471768934,0,0,3
253,Androgen receptor signaling pathway WP138,0.4865508388529596,1.078322587094517,0.7768385627767077,"['CDKN1A', 'LIMK2', 'STAT3', 'DSTN', 'STUB1', 'CALR', 'RHOB']",0.8544621471768934,0,0,7
254,Overview of interferons-mediated signaling pathway WP4558,0.48985117959391,1.2796452876881832,0.9132235291413522,"['IFNAR2', 'IL10RB']",0.8544621471768934,0,0,2
255,SARS-CoV-2 mitochondrial interactions WP5038,0.48985117959391,1.2796452876881832,0.9132235291413522,"['TMEM173', 'IKBKE']",0.8544621471768934,0,0,2
256,15q13.3 copy number variation syndrome WP4942,0.49430175825932116,1.663453815261044,1.1720846983346869,['OTUD7A'],0.8544621471768934,0,0,1
257,Aspirin and miRNAs WP4707,0.49430175825932116,1.663453815261044,1.1720846983346869,['PDK1'],0.8544621471768934,0,0,1
258,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.49430175825932116,1.663453815261044,1.1720846983346869,['SMAD6'],0.8544621471768934,0,0,1
259,Cytokines and Inflammatory Response WP530,0.49430175825932116,1.663453815261044,1.1720846983346869,['IL15'],0.8544621471768934,0,0,1
260,Fatty acid transporters WP5061,0.49430175825932116,1.663453815261044,1.1720846983346869,['ACSL1'],0.8544621471768934,0,0,1
261,FOXP3 in COVID-19 WP5063,0.49430175825932116,1.663453815261044,1.1720846983346869,['STAT3'],0.8544621471768934,0,0,1
262,Glial Cell Differentiation WP2276,0.49430175825932116,1.663453815261044,1.1720846983346869,['GAP43'],0.8544621471768934,0,0,1
263,LDLRAD4 and what we know about it WP4904,0.49430175825932116,1.663453815261044,1.1720846983346869,['PMEPA1'],0.8544621471768934,0,0,1
264,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.49430175825932116,1.663453815261044,1.1720846983346869,['HMGCS1'],0.8544621471768934,0,0,1
265,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.49430175825932116,1.663453815261044,1.1720846983346869,['ITGAV'],0.8544621471768934,0,0,1
266,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.49430175825932116,1.663453815261044,1.1720846983346869,['PPARD'],0.8544621471768934,0,0,1
267,Pilocytic astrocytoma WP2253,0.49430175825932116,1.663453815261044,1.1720846983346869,['GRB2'],0.8544621471768934,0,0,1
268,Selective expression of chemokine receptors during T-cell polarization WP4494,0.49430175825932116,1.663453815261044,1.1720846983346869,['IL4R'],0.8544621471768934,0,0,1
269,Vitamin A and carotenoid metabolism WP716,0.49430175825932116,1.663453815261044,1.1720846983346869,['BCO2'],0.8544621471768934,0,0,1
270,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5124030000860558,1.1341061622940818,0.7583131152103273,"['MAP1LC3A', 'IGF1', 'PDK1']",0.8727743408059191,0,0,3
271,G1 to S cell cycle control WP45,0.5124030000860558,1.1341061622940818,0.7583131152103273,"['CDKN1A', 'CCND3', 'E2F3']",0.8727743408059191,0,0,3
272,Metabolic reprogramming in colon cancer WP4290,0.5124030000860558,1.1341061622940818,0.7583131152103273,"['PGAM1', 'SLC1A5', 'SLC16A3']",0.8727743408059191,0,0,3
273,p38 MAPK Signaling Pathway WP400,0.5124030000860558,1.1341061622940818,0.7583131152103273,"['RPS6KA5', 'GRB2', 'MAP2K6']",0.8727743408059191,0,0,3
274,16p11.2 distal deletion syndrome WP4950,0.525154366564059,1.1880505553427805,0.7651794381609264,"['INSR', 'GRB2']",0.8822571968482632,0,0,2
275,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.525154366564059,1.1880505553427805,0.7651794381609264,"['ATG3', 'MAP1LC3A']",0.8822571968482632,0,0,2
276,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.525154366564059,1.1880505553427805,0.7651794381609264,"['PTPN1', 'CEBPB']",0.8822571968482632,0,0,2
277,Endometrial cancer WP4155,0.5272058999419434,1.0730142212972598,0.6869051883798738,"['CDKN1A', 'BAX', 'CTNNA3', 'GRB2']",0.8822571968482632,0,0,4
278,Amyotrophic lateral sclerosis (ALS) WP2447,0.5396973472229891,1.084622118470966,0.6689371824351786,"['CASP1', 'BAX', 'MAP2K6']",0.8822571968482632,0,0,3
279,Cell cycle WP179,0.5480605432956301,1.0180427966334782,0.612219905579056,"['CCND3', 'CDKN1A', 'E2F3', 'YWHAG', 'ANAPC11', 'YWHAH']",0.8822571968482632,0,0,6
280,Cell Differentiation - Index expanded WP2023,0.5486496699574493,1.3859883980365908,0.8320021342252505,['STAT3'],0.8822571968482632,0,0,1
281,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.5486496699574493,1.3859883980365908,0.8320021342252505,['STAT3'],0.8822571968482632,0,0,1
282,Dual hijack model of Vif in HIV infection WP3300,0.5486496699574493,1.3859883980365908,0.8320021342252505,['RUNX1'],0.8822571968482632,0,0,1
283,Estrogen Receptor Pathway WP2881,0.5486496699574493,1.3859883980365908,0.8320021342252505,['STAT3'],0.8822571968482632,0,0,1
284,FOXA2 pathway WP5066,0.5486496699574493,1.3859883980365908,0.8320021342252505,['PPARGC1B'],0.8822571968482632,0,0,1
285,Galanin receptor pathway WP4970,0.5486496699574493,1.3859883980365908,0.8320021342252505,['CDKN1A'],0.8822571968482632,0,0,1
286,Nanoparticle triggered regulated necrosis WP2513,0.5486496699574493,1.3859883980365908,0.8320021342252505,['FTL'],0.8822571968482632,0,0,1
287,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5486496699574493,1.3859883980365908,0.8320021342252505,['ANAPC11'],0.8822571968482632,0,0,1
288,Type III interferon signaling WP2113,0.5486496699574493,1.3859883980365908,0.8320021342252505,['IL10RB'],0.8822571968482632,0,0,1
289,AMP-activated protein kinase (AMPK) signaling WP1403,0.5502249184645083,1.0393145161290323,0.6209157399994363,"['CDKN1A', 'PFKFB3', 'INSR', 'PPARGC1B']",0.8822571968482632,0,0,4
290,Modulators of TCR signaling and T cell activation WP5072,0.5502249184645083,1.0393145161290323,0.6209157399994363,"['NDUFB10', 'TNFAIP3', 'MAP3K8', 'GRB2']",0.8822571968482632,0,0,4
291,Intraflagellar transport proteins binding to dynein WP4532,0.5587690941570383,1.108668453976765,0.6452660612892803,"['DYNLT3', 'DYNLL1']",0.8843347913578533,0,0,2
292,Physiological and pathological hypertrophy of the heart WP1528,0.5587690941570383,1.108668453976765,0.6452660612892803,"['STAT3', 'CALM2']",0.8843347913578533,0,0,2
293,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.5587690941570383,1.108668453976765,0.6452660612892803,"['CALM2', 'PDK1']",0.8843347913578533,0,0,2
294,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.5660920415131019,1.039261744966443,0.5913384742669097,"['XBP1', 'MAP1LC3A', 'HSPA5']",0.8843347913578533,0,0,3
295,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5660920415131019,1.039261744966443,0.5913384742669097,"['IFNAR2', 'OAS1', 'IKBKE']",0.8843347913578533,0,0,3
296,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5726406040381556,1.0076572173346368,0.5617658526517675,"['MAP3K8', 'GRB2', 'CALM2', 'PDK1']",0.8843347913578533,0,0,4
297,Circadian rhythm related genes WP3594,0.5763494377696914,0.9776821297624742,0.5387430747916283,"['PER3', 'DBP', 'KCNH7', 'NAMPT', 'BHLHE40', 'NR1D2', 'RORA', 'NR1D1', 'RPS27A', 'ARNTL']",0.8843347913578533,0,0,10
298,IL-7 signaling pathway WP205,0.5906505375430445,1.0392091152815013,0.5471755481219305,"['STAT3', 'JAK3']",0.8843347913578533,0,0,2
299,Nanoparticle-mediated activation of receptor signaling WP2643,0.5906505375430445,1.0392091152815013,0.5471755481219305,"['PXN', 'GRB2']",0.8843347913578533,0,0,2
300,TLR4 Signaling and Tolerance WP3851,0.5906505375430445,1.0392091152815013,0.5471755481219305,"['IKBKE', 'TLR4']",0.8843347913578533,0,0,2
301,Base Excision Repair WP4752,0.59716370857283,1.1877988143048384,0.6123862894465852,['APEX1'],0.8843347913578533,0,0,1
302,BMP Signaling Pathway in Eyelid Development WP3927,0.59716370857283,1.1877988143048384,0.6123862894465852,['NOTCH1'],0.8843347913578533,0,0,1
303,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.59716370857283,1.1877988143048384,0.6123862894465852,['RYR2'],0.8843347913578533,0,0,1
304,Cytosine methylation WP3585,0.59716370857283,1.1877988143048384,0.6123862894465852,['IDH1'],0.8843347913578533,0,0,1
305,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.59716370857283,1.1877988143048384,0.6123862894465852,['PPARD'],0.8843347913578533,0,0,1
306,ERK Pathway in Huntington's Disease WP3853,0.59716370857283,1.1877988143048384,0.6123862894465852,['RPS6KA5'],0.8843347913578533,0,0,1
307,Globo Sphingolipid Metabolism WP1424,0.59716370857283,1.1877988143048384,0.6123862894465852,['ST6GALNAC5'],0.8843347913578533,0,0,1
308,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.59716370857283,1.1877988143048384,0.6123862894465852,['UGCG'],0.8843347913578533,0,0,1
309,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.59716370857283,1.1877988143048384,0.6123862894465852,['ACSL1'],0.8843347913578533,0,0,1
310,NAD+ biosynthetic pathways WP3645,0.59716370857283,1.1877988143048384,0.6123862894465852,['NAMPT'],0.8843347913578533,0,0,1
311,Neuroinflammation WP4919,0.59716370857283,1.1877988143048384,0.6123862894465852,['TLR4'],0.8843347913578533,0,0,1
312,Ovarian infertility WP34,0.59716370857283,1.1877988143048384,0.6123862894465852,['CEBPB'],0.8843347913578533,0,0,1
313,RalA downstream regulated genes WP2290,0.59716370857283,1.1877988143048384,0.6123862894465852,['YBX3'],0.8843347913578533,0,0,1
314,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.59716370857283,1.1877988143048384,0.6123862894465852,['STAT3'],0.8843347913578533,0,0,1
315,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6017960455030257,0.9588430437487041,0.486935673657403,"['NOTCH1', 'WNT5A', 'GRB2', 'RBPJ', 'HIF1A', 'MAP2K6']",0.888365590980657,0,0,6
316,Ebola Virus Pathway on Host WP4217,0.609537483829351,0.9494980694980695,0.4700536078892404,"['BST2', 'SCIN', 'ITGAV', 'IQGAP1', 'IKBKE', 'TLR4', 'ACTG1', 'RHOB']",0.8945982108880158,0,0,8
317,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6207829203688001,0.9779214634915628,0.4662473545315173,"['RAB3A', 'LITAF']",0.8945982108880158,0,0,2
318,Notch Signaling WP268,0.6207829203688001,0.9779214634915628,0.4662473545315173,"['NOTCH1', 'RBPJ']",0.8945982108880158,0,0,2
319,Common Pathways Underlying Drug Addiction WP2636,0.6394492057247718,0.9233407904548844,0.412870070156393,"['GRM5', 'CALM2', 'ACTG1']",0.8945982108880158,0,0,3
320,PDGF Pathway WP2526,0.6394492057247718,0.9233407904548844,0.412870070156393,"['STAT3', 'PDGFB', 'GRB2']",0.8945982108880158,0,0,3
321,TGF-beta Receptor Signaling WP560,0.6394492057247718,0.9233407904548844,0.412870070156393,"['STAT3', 'SPP1', 'SMAD6']",0.8945982108880158,0,0,3
322,1q21.1 copy number variation syndrome WP4905,0.6404693507551638,1.0391566265060241,0.4630004028420796,['GJA1'],0.8945982108880158,0,0,1
323,Cholesterol Biosynthesis Pathway WP197,0.6404693507551638,1.0391566265060241,0.4630004028420796,['HMGCS1'],0.8945982108880158,0,0,1
324,Computational Model of Aerobic Glycolysis WP4629,0.6404693507551638,1.0391566265060241,0.4630004028420796,['TPI1'],0.8945982108880158,0,0,1
325,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6404693507551638,1.0391566265060241,0.4630004028420796,['BAX'],0.8945982108880158,0,0,1
326,PPAR-alpha pathway WP2878,0.6404693507551638,1.0391566265060241,0.4630004028420796,['PLTP'],0.8945982108880158,0,0,1
327,Purine metabolism and related disorders WP4224,0.6404693507551638,1.0391566265060241,0.4630004028420796,['GRM5'],0.8945982108880158,0,0,1
328,Urea cycle and associated pathways WP4595,0.6404693507551638,1.0391566265060241,0.4630004028420796,['OAT'],0.8945982108880158,0,0,1
329,Glycerophospholipid Biosynthetic Pathway WP2533,0.6491738076666261,0.9234435507893953,0.39897820914460036,"['PGS1', 'GK']",0.8945982108880158,0,0,2
330,Focal Adhesion WP306,0.6541569557678242,0.9113172051882901,0.38677027850943435,"['CCND3', 'PXN', 'PDGFB', 'SPP1', 'GRB2', 'ITGAV', 'IGF1', 'DOCK1', 'ACTG1']",0.8945982108880158,0,0,9
331,MET in type 1 papillary renal cell carcinoma WP4205,0.6556116280818665,0.8981400755594304,0.3791827907943549,"['CDKN1A', 'STAT3', 'GRB2', 'JAK3']",0.8945982108880158,0,0,4
332,VEGFA-VEGFR2 Signaling Pathway WP3888,0.6568470529021431,0.9361559139784946,0.39347015370962934,"['HDAC4', 'FLII', 'PXN', 'HTRA1', 'IQGAP1', 'LDB2', 'RPL10A', 'SLC7A1', 'RPL7', 'ACTG1', 'GJA1', 'RPS6KA5', 'TMSB4X', 'ITGAV', 'RPS11', 'TMSB10', 'MAP2K6', 'PTPN1', 'HSP90AA1', 'STAT3', 'PTPN14', 'TXNIP', 'CYCS', 'GRB2', 'RPL26', 'CALR', 'PFN1', 'HSPA1A']",0.8945982108880158,0,0,28
333,Cytosolic DNA-sensing pathway WP4655,0.6618763762363576,0.8902205177372963,0.3673730726472615,"['CASP1', 'TMEM173', 'IKBKE']",0.8945982108880158,0,0,3
334,IL-2 signaling pathway WP49,0.6618763762363576,0.8902205177372963,0.3673730726472615,"['STAT3', 'GRB2', 'JAK3']",0.8945982108880158,0,0,3
335,Prolactin Signaling Pathway WP2037,0.6700058717351665,0.8835657627215715,0.35384052323785387,"['PTPN1', 'PXN', 'STAT3', 'GRB2', 'YWHAG']",0.8945982108880158,0,0,5
336,AGE/RAGE pathway WP2324,0.6745734981554712,0.8743633276740238,0.3442146703482847,"['INSR', 'STAT3', 'CYCS', 'HIF1A']",0.8945982108880158,0,0,4
337,Interferon type I signaling pathways WP585,0.6745734981554712,0.8743633276740238,0.3442146703482847,"['IFNAR2', 'RPS6KA5', 'STAT3', 'MAP2K6']",0.8945982108880158,0,0,4
338,Airway smooth muscle cell contraction WP4962,0.6791250934268163,0.9235460359958352,0.3573660800213388,['CALM2'],0.8945982108880158,0,0,1
339,Autosomal recessive Osteopetrosis pathways WP4788,0.6791250934268163,0.9235460359958352,0.3573660800213388,['TCIRG1'],0.8945982108880158,0,0,1
340,Cancer immunotherapy by PD-1 blockade WP4585,0.6791250934268163,0.9235460359958352,0.3573660800213388,['STAT3'],0.8945982108880158,0,0,1
341,Constitutive Androstane Receptor Pathway WP2875,0.6791250934268163,0.9235460359958352,0.3573660800213388,['HSP90AA1'],0.8945982108880158,0,0,1
342,Eicosanoid Synthesis WP167,0.6791250934268163,0.9235460359958352,0.3573660800213388,['LTC4S'],0.8945982108880158,0,0,1
343,Gastric Cancer Network 1 WP2361,0.6791250934268163,0.9235460359958352,0.3573660800213388,['NOTCH1'],0.8945982108880158,0,0,1
344,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6791250934268163,0.9235460359958352,0.3573660800213388,['WNT5A'],0.8945982108880158,0,0,1
345,Kallmann's Syndrome WP5074,0.6791250934268163,0.9235460359958352,0.3573660800213388,['GRB2'],0.8945982108880158,0,0,1
346,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.6791250934268163,0.9235460359958352,0.3573660800213388,['MAP2K6'],0.8945982108880158,0,0,1
347,Methionine De Novo and Salvage Pathway WP3580,0.6791250934268163,0.9235460359958352,0.3573660800213388,['SRM'],0.8945982108880158,0,0,1
348,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6791250934268163,0.9235460359958352,0.3573660800213388,['HMOX1'],0.8945982108880158,0,0,1
349,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6791250934268163,0.9235460359958352,0.3573660800213388,['SLC2A3'],0.8945982108880158,0,0,1
350,Pregnane X receptor pathway WP2876,0.6791250934268163,0.9235460359958352,0.3573660800213388,['HSP90AA1'],0.8945982108880158,0,0,1
351,Sleep regulation WP3591,0.6791250934268163,0.9235460359958352,0.3573660800213388,['PER3'],0.8945982108880158,0,0,1
352,Striated Muscle Contraction Pathway WP383,0.6791250934268163,0.9235460359958352,0.3573660800213388,['ACTG1'],0.8945982108880158,0,0,1
353,Wnt signaling in kidney disease WP4150,0.6791250934268163,0.9235460359958352,0.3573660800213388,['WNT5A'],0.8945982108880158,0,0,1
354,Energy Metabolism WP1541,0.6832748267302251,0.8593844017588521,0.3273035264102349,"['ESRRA', 'PPARGC1B', 'PPARD']",0.8949937871255061,0,0,3
355,Metapathway biotransformation Phase I and II WP702,0.6832748267302251,0.8593844017588521,0.3273035264102349,"['SULT4A1', 'HS3ST4', 'GAL3ST4']",0.8949937871255061,0,0,3
356,Autophagy WP4923,0.7008499115116215,0.8308310991957104,0.29532848632365744,"['ATG3', 'ATG14']",0.9114096922258663,0,0,2
357,miRNA regulation of prostate cancer signaling pathways WP3981,0.7008499115116215,0.8308310991957104,0.29532848632365744,"['CDKN1A', 'GRB2']",0.9114096922258663,0,0,2
358,Thermogenesis WP4321,0.7026583681713016,0.8472271815859588,0.29897331330130994,"['ACSL1', 'GRB2', 'MGLL', 'ACTG1', 'CREB5']",0.9114096922258663,0,0,5
359,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7036474828152387,0.8306040268456376,0.29193886179942474,"['STAT3', 'SPP1', 'SMAD6']",0.9114096922258663,0,0,3
360,Imatinib and Chronic Myeloid Leukemia WP3640,0.7136296172872532,0.8310575635876841,0.2803915041033432,['PIM1'],0.9192182050929991,0,0,1
361,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.7136296172872532,0.8310575635876841,0.2803915041033432,['IDH1'],0.9192182050929991,0,0,1
362,Chemokine signaling pathway WP3929,0.7185053757425658,0.851004851004851,0.28132696360237147,"['CX3CR1', 'GNG10', 'GNG3', 'CXCL12', 'PXN', 'STAT3', 'GRB2', 'JAK3']",0.9226308776742126,0,0,8
363,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7230040775740091,0.8036804503139208,0.26066605242267626,"['CXCL12', 'TMEM173', 'IKBKE']",0.9226308776742126,0,0,3
364,Insulin Signaling WP481,0.7260418339340101,0.8550554577710725,0.27374398971230096,"['SNAP25', 'PTPN1', 'XBP1', 'RPS6KA5', 'TBC1D4', 'INSR', 'ENPP1', 'MAP3K8', 'GRB2', 'MAP2K6']",0.9226308776742126,0,0,10
365,Wnt signaling pathway and pluripotency WP399,0.7270373086708263,0.8099921321793863,0.2582072540357157,"['CCND3', 'LRRK2', 'WNT5A', 'PPARD']",0.9226308776742126,0,0,4
366,Fragile X Syndrome  WP4549,0.730585698454995,0.8400957919945262,0.26371341144432636,"['GRIP1', 'GRM5', 'DUSP3', 'GRB2', 'SLC6A1', 'GRIN2B', 'PDK1', 'HCN1']",0.9226308776742126,0,0,8
367,Ras signaling WP4223,0.739110672316699,0.8386827021027504,0.2535401629562217,"['GNG10', 'GNG3', 'INSR', 'CALM3', 'GRB2', 'KSR2', 'GRIN2B', 'CALM2', 'RASGRP3']",0.9226308776742126,0,0,9
368,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.7444281860769592,0.7553851770719241,0.22294354326956528,['MAP2K6'],0.9226308776742126,0,0,1
369,Ebstein-Barr virus LMP1 signaling WP262,0.7444281860769592,0.7553851770719241,0.22294354326956528,['HSP90AA1'],0.9226308776742126,0,0,1
370,Endothelin Pathways WP2197,0.7444281860769592,0.7553851770719241,0.22294354326956528,['CALM2'],0.9226308776742126,0,0,1
371,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7444281860769592,0.7553851770719241,0.22294354326956528,['CDKN1A'],0.9226308776742126,0,0,1
372,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7444281860769592,0.7553851770719241,0.22294354326956528,['BAX'],0.9226308776742126,0,0,1
373,MAPK Cascade WP422,0.7460413118397934,0.7550572751645138,0.2212123785466801,"['GRB2', 'MAP2K6']",0.9226308776742126,0,0,2
374,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7460413118397934,0.7550572751645138,0.2212123785466801,"['CCND3', 'WNT5A']",0.9226308776742126,0,0,2
375,PDGFR-beta pathway WP3972,0.7460413118397934,0.7550572751645138,0.2212123785466801,"['STAT3', 'GRB2']",0.9226308776742126,0,0,2
376,Target Of Rapamycin (TOR) Signaling WP1471,0.7460413118397934,0.7550572751645138,0.2212123785466801,"['PRR5', 'DDIT4']",0.9226308776742126,0,0,2
377,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7587360417777769,0.7547284929835265,0.20838154305387402,"['IFI27L2', 'TLR4', 'TLR2']",0.9358415369407592,0,0,3
378,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7719183612549514,0.6923248549754574,0.1792266243934779,['NAMPT'],0.9411165413790251,0,0,1
379,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.7719183612549514,0.6923248549754574,0.1792266243934779,['RPS6KA5'],0.9411165413790251,0,0,1
380,Pathways in clear cell renal cell carcinoma WP4018,0.7729255561141145,0.7543988269794721,0.19431242218050784,"['TPI1', 'STAT3', 'PDGFB', 'HIF1A']",0.9411165413790251,0,0,4
381,Pathways Regulating Hippo Signaling WP4540,0.7729255561141145,0.7543988269794721,0.19431242218050784,"['INSR', 'CDH12', 'CDH8', 'CDH18']",0.9411165413790251,0,0,4
382,G Protein Signaling Pathways WP35,0.7741838944994784,0.768157120781616,0.19660662246462884,"['GNG10', 'GNG3', 'PDE4D', 'PDE4B', 'CALM2']",0.9411165413790251,0,0,5
383,22q11.2 copy number variation syndrome WP4657,0.7751562050498207,0.7324121594946703,0.1865385766022136,"['OAT', 'EMC10', 'ARNTL']",0.9411165413790251,0,0,3
384,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.780766777238279,0.8020865162163342,0.19849940406347236,"['GRIP1', 'RAB3A', 'RPS6KA5', 'STAT3', 'NCK2', 'SPP1', 'GRB2', 'YBX1', 'GRIN2B']",0.9454597693119785,0,0,9
385,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7852459896730356,0.6919124218051832,0.1672755346206308,"['CYCS', 'ACTG1']",0.9459569564714031,0,0,2
386,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7852459896730356,0.6919124218051832,0.1672755346206308,"['BST2', 'MAP2K6']",0.9459569564714031,0,0,2
387,Cell migration and invasion through p75NTR WP4561,0.7964551063113572,0.6389661208938318,0.14541879467555127,['STAT3'],0.9471908553319209,0,0,1
388,Ethanol effects on histone modifications WP3996,0.7964551063113572,0.6389661208938318,0.14541879467555127,['HDAC4'],0.9471908553319209,0,0,1
389,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.7964551063113572,0.6389661208938318,0.14541879467555127,['ANGPT2'],0.9471908553319209,0,0,1
390,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7964551063113572,0.6389661208938318,0.14541879467555127,['RAB27A'],0.9471908553319209,0,0,1
391,MTHFR deficiency WP4288,0.7964551063113572,0.6389661208938318,0.14541879467555127,['CYCS'],0.9471908553319209,0,0,1
392,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8183553458085407,0.5932300631095812,0.11891808491206327,['BAX'],0.9664340150654971,0,0,1
393,B Cell Receptor Signaling Pathway WP23,0.8206706614849076,0.7313302679562391,0.14453528236632474,"['BCL6', 'GRB2', 'E2F3', 'PIK3AP1', 'RASGRP3', 'MAP2K6']",0.9664340150654971,0,0,6
394,Amino Acid metabolism WP3925,0.831868042808626,0.654892264217591,0.12055351964279787,"['OAT', 'IDH1', 'SRM']",0.9664340150654971,0,0,3
395,Osteoblast differentiation WP4787,0.831868042808626,0.654892264217591,0.12055351964279787,"['NOTCH1', 'WNT5A', 'RBPJ']",0.9664340150654971,0,0,3
396,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8340666904350071,0.6147353788104458,0.11153876451560625,"['CCND3', 'WNT5A']",0.9664340150654971,0,0,2
397,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8356457110428961,0.6768707482993197,0.12153251265911613,"['HMGCS1', 'SCD', 'SEC24D', 'PPARGC1B']",0.9664340150654971,0,0,4
398,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8379020365678939,0.5535921463632307,0.09790503350685642,['WNT5A'],0.9664340150654971,0,0,1
399,miRNAs involvement in the immune response in sepsis WP4329,0.8379020365678939,0.5535921463632307,0.09790503350685642,['TLR4'],0.9664340150654971,0,0,1
400,Oxidative Stress WP408,0.8379020365678939,0.5535921463632307,0.09790503350685642,['HMOX1'],0.9664340150654971,0,0,1
401,Proximal tubule transport WP4917,0.8379020365678939,0.5535921463632307,0.09790503350685642,['ATP6V1F'],0.9664340150654971,0,0,1
402,Sphingolipid pathway WP1422,0.8379020365678939,0.5535921463632307,0.09790503350685642,['UGCG'],0.9664340150654971,0,0,1
403,Vitamin D in inflammatory diseases WP4482,0.8379020365678939,0.5535921463632307,0.09790503350685642,['MAP2K6'],0.9664340150654971,0,0,1
404,Gastrin signaling pathway WP4659,0.841705790037966,0.6906684611933602,0.11901926563118534,"['CDKN1A', 'PXN', 'STAT3', 'GRB2', 'RHOB']",0.9664340150654971,0,0,5
405,IL-1 signaling pathway WP195,0.8439675996639512,0.6379969024264326,0.10823054362964901,"['IRAK2', 'IL1RAP', 'MAP2K6']",0.9664340150654971,0,0,3
406,Genotoxicity pathway WP4286,0.8479679099929524,0.5926847950976637,0.09774112291214115,"['CDKN1A', 'CEBPD']",0.9664340150654971,0,0,2
407,Interleukin-11 Signaling Pathway WP2332,0.8479679099929524,0.5926847950976637,0.09774112291214115,"['STAT3', 'GRB2']",0.9664340150654971,0,0,2
408,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8479679099929524,0.5926847950976637,0.09774112291214115,"['IFNAR2', 'CXCL12']",0.9664340150654971,0,0,2
409,Alpha 6 Beta 4 signaling pathway WP244,0.8553478042759698,0.518908969210174,0.08107802374854645,['GRB2'],0.9688483588849193,0,0,1
410,Leptin signaling pathway WP2034,0.8563369365627995,0.6501159603626396,0.10082737027556589,"['PTPN1', 'STAT3', 'BAX', 'GRB2']",0.9688483588849193,0,0,4
411,Pancreatic adenocarcinoma pathway WP4263,0.8563369365627995,0.6501159603626396,0.10082737027556589,"['CDKN1A', 'STAT3', 'BAX', 'E2F3']",0.9688483588849193,0,0,4
412,IL-6 signaling pathway WP364,0.8608017794398753,0.572154941296108,0.08576088911269654,"['STAT3', 'GRB2']",0.9715359889309273,0,0,2
413,Kit receptor signaling pathway WP304,0.8659162037339028,0.6066786708135538,0.08734179163963826,"['STAT3', 'GRB2', 'SOCS6']",0.9749419727270333,0,0,3
414,GABA receptor Signaling WP4159,0.8709181906348117,0.4883061658398299,0.06748744371203115,['SLC6A1'],0.977604413359259,0,0,1
415,IL-5 signaling pathway WP127,0.8726368801706095,0.552993744414656,0.0753375200004226,"['STAT3', 'GRB2']",0.977604413359259,0,0,2
416,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8758361011829767,0.5921380632790029,0.0785034762763765,"['CDKN1A', 'CYCS', 'BAX']",0.977604413359259,0,0,3
417,Splicing factor NOVA regulated synaptic proteins WP4148,0.8835393925491297,0.5350687537836202,0.0662518927426581,"['EPB41L3', 'GRIN2B']",0.977604413359259,0,0,2
418,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8835393925491297,0.5350687537836202,0.0662518927426581,"['CACNA1C', 'GRIN2B']",0.977604413359259,0,0,2
419,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8848145535453956,0.46110367395507956,0.05642857650441558,['BAX'],0.977604413359259,0,0,1
420,Type II interferon signaling (IFNG) WP619,0.8848145535453956,0.46110367395507956,0.05642857650441558,['OAS1'],0.977604413359259,0,0,1
421,Head and Neck Squamous Cell Carcinoma WP4674,0.8850999097295658,0.5782737630716404,0.07058105842456813,"['CDKN1A', 'NOTCH1', 'DDIT4']",0.977604413359259,0,0,3
422,ErbB signaling pathway WP673,0.8911233109763766,0.6024437927663734,0.06944518097374283,"['CDKN1A', 'NCK2', 'NRG1', 'GRB2']",0.9816605780184592,0,0,4
423,ATM Signaling Pathway WP2516,0.8972166573286992,0.43676460226872404,0.0473705761882198,['CDKN1A'],0.9816605780184592,0,0,1
424,Nephrotic syndrome WP4758,0.8972166573286992,0.43676460226872404,0.0473705761882198,['E2F3'],0.9816605780184592,0,0,1
425,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8972166573286992,0.43676460226872404,0.0473705761882198,['VMP1'],0.9816605780184592,0,0,1
426,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9062021474809512,0.6283735371387629,0.06189031749529955,"['PTPN1', 'RPS6KA5', 'SCD', 'INSR', 'MAP3K8', 'MAP2K6']",0.9891159677719146,0,0,6
427,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.908284985459371,0.41485943775100403,0.039908270250312516,['PDK1'],0.9891159677719146,0,0,1
428,Corticotropin-releasing hormone signaling pathway WP2355,0.9162725856585182,0.5287162644580894,0.04623167766737416,"['GJA1', 'HSP90AA1', 'TLR4']",0.9909477651377366,0,0,3
429,Glioblastoma signaling pathways WP2261,0.9162725856585182,0.5287162644580894,0.04623167766737416,"['CDKN1A', 'GRB2', 'MAP2K6']",0.9909477651377366,0,0,3
430,Integrated breast cancer pathway WP1984,0.9172332169434505,0.6126584805830089,0.05292971844324052,"['USP15', 'BAX', 'FAU', 'SMAD6', 'BACH1', 'RASGRP3']",0.9909477651377366,0,0,6
431,Rett syndrome causing genes WP4312,0.919050010697836,0.47361164304864034,0.03997980347318908,"['CECR2', 'GRIN2B']",0.9909477651377366,0,0,2
432,Translation Factors WP107,0.9261834106962996,0.4603812928209711,0.03530341694736468,"['EIF4A2', 'EEF1B2']",0.9909477651377366,0,0,2
433,IL-3 signaling pathway WP286,0.9327207252272426,0.4478660966596623,0.031193628567747538,"['STAT3', 'GRB2']",0.9909477651377366,0,0,2
434,BDNF-TrkB Signaling WP3676,0.9348447906679023,0.3605727256853501,0.02429350185024425,['GRB2'],0.9909477651377366,0,0,1
435,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.9348447906679023,0.3605727256853501,0.02429350185024425,['PDK1'],0.9909477651377366,0,0,1
436,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9348447906679023,0.3605727256853501,0.02429350185024425,['STAT3'],0.9909477651377366,0,0,1
437,Neural Crest Cell Migration during Development WP4564,0.9348447906679023,0.3605727256853501,0.02429350185024425,['STAT3'],0.9909477651377366,0,0,1
438,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9481297736692382,0.331619812583668,0.017663362558961226,['HDAC4'],0.9909477651377366,0,0,1
439,T-cell receptor (TCR) signaling pathway WP69,0.9529059148366594,0.4596569724086503,0.02217344116362464,"['CD83', 'MAP3K8', 'GRB2']",0.9909477651377366,0,0,3
440,EGF/EGFR signaling pathway WP437,0.9534060355145223,0.5893822393822394,0.028122023291013216,"['GJA1', 'PLSCR1', 'RPS6KA5', 'LIMK2', 'STAT3', 'NCK2', 'GRB2', 'IQGAP1']",0.9909477651377366,0,0,8
441,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9537201784783977,0.31881371640407785,0.015106976641172777,['ACTG1'],0.9909477651377366,0,0,1
442,Neural Crest Cell Migration in Cancer WP4565,0.9537201784783977,0.31881371640407785,0.015106976641172777,['STAT3'],0.9909477651377366,0,0,1
443,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9537201784783977,0.31881371640407785,0.015106976641172777,['STAT3'],0.9909477651377366,0,0,1
444,TGF-beta Signaling Pathway WP366,0.9555805134172544,0.5229398436035914,0.02376042846295722,"['CDKN1A', 'LIMK2', 'GRB2', 'PDK1', 'MAP2K6']",0.9909477651377366,0,0,5
445,Pathways affected in adenoid cystic carcinoma WP3651,0.9579612644636716,0.3942295416826248,0.016931344960998105,"['NOTCH1', 'NFIB']",0.9909477651377366,0,0,2
446,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9587087587378162,0.30695621994149436,0.01294371235036631,['GRB2'],0.9909477651377366,0,0,1
447,Male infertility WP4673,0.9617810130350336,0.3849990647795997,0.015002832747730599,"['INSR', 'ARNTL']",0.9909477651377366,0,0,2
448,ATM Signaling Network in Development and Disease  WP3878,0.9631602250976514,0.29594568751195255,0.011108469300837294,['HDAC4'],0.9909477651377366,0,0,1
449,Copper homeostasis WP3286,0.9631602250976514,0.29594568751195255,0.011108469300837294,['STEAP3'],0.9909477651377366,0,0,1
450,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9631602250976514,0.29594568751195255,0.011108469300837294,['BAX'],0.9909477651377366,0,0,1
451,Proteasome Degradation WP183,0.9652664915962476,0.37618815500853037,0.013298649539773787,"['PSMD5', 'H2AFZ']",0.9909477651377366,0,0,2
452,Mesodermal commitment pathway WP2857,0.9664605010072137,0.4276787780606341,0.01459019703758996,"['BHLHE40', 'RPL38', 'SMAD6']",0.9909477651377366,0,0,3
453,Ciliary landscape WP4352,0.9677811026582865,0.5748497340844007,0.018825955653481687,"['CTSA', 'DOCK5', 'TBC1D4', 'DYNLT3', 'IQGAP1', 'IQGAP2', 'DYNLL1', 'COX6C', 'CALM2']",0.9909477651377366,0,0,9
454,Wnt signaling WP428,0.9684453261810159,0.36776884122728626,0.011791864220293663,"['CCND3', 'WNT5A']",0.9909477651377366,0,0,2
455,16p11.2 proximal deletion syndrome WP4949,0.9713430737784146,0.35971558456696584,0.01045892955604862,"['MVP', 'MAP2K6']",0.9909477651377366,0,0,2
456,Ciliopathies WP4803,0.9717681309737806,0.41328859060402684,0.01183577988412627,"['KIAA0586', 'MAK', 'CCDC65']",0.9909477651377366,0,0,3
457,Regulation of Microtubule Cytoskeleton WP2038,0.9766610304752328,0.258785140562249,0.006111375811185906,['STAT3'],0.9915881641287845,0,0,1
458,Wnt Signaling Pathway WP363,0.9766610304752328,0.258785140562249,0.006111375811185906,['GJA1'],0.9915881641287845,0,0,1
459,RANKL/RANK signaling pathway WP2018,0.9791788223115683,0.2509026003001907,0.005279240358213786,['MAP2K6'],0.9919785454790397,0,0,1
460,Joubert Syndrome WP4656,0.983429639424788,0.23648881239242686,0.0039515352490461985,['KIAA0586'],0.9941190920272314,0,0,1
461,Genes related to primary cilium development (based on CRISPR) WP4536,0.9868134293212895,0.22363327182604292,0.002968571888568392,['DYNLL1'],0.9946540148064296,0,0,1
462,DNA IR-damage and cellular response via ATR WP4016,0.988236892130259,0.217712957091524,0.0025761627203742953,['BCL6'],0.9946540148064296,0,0,1
463,mRNA Processing WP411,0.994706326003242,0.3540871777084056,0.0018794009537238488,"['LSM7', 'SNRPD1', 'SNRPG', 'YBX1']",0.9990031135885693,0,0,4
464,DNA Repair Pathways Full Network WP4946,0.9984977163036215,0.14730349971313828,0.00022145803411681422,['APEX1'],0.999397886348303,0,0,1
465,Endoderm differentiation WP2853,0.999397886348303,0.12872322623828647,7.752935489305567e-05,['NOTCH1'],0.999397886348303,0,0,1
